SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Poly Medicure informs about unaudited financial results

03 Feb 2025 Evaluate
Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, Poly Medicure has informed that the Board of Directors at their meeting held today i.e. 03rd February, 2025, at 232-B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi - 110020, approved the following businesses: a) Unaudited Financial Results (Consolidate & Standalone) for the Third quarter and Nine Months ended on 31st December, 2024. b) Other businesses item. The Meeting was started at 12.00 noon and concluded on 02.00 pm.

The above information is a part of company’s filings submitted to BSE.

Poly Medicure Share Price

1651.20 -28.30 (-1.69%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 489.50
Poly Medicure 1651.20
Laxmi Denta 214.95
Nureca Ltd. 289.30
Hemant Surgical Inds 301.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×